相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Soluble-HLA-E: A follow up biomarker in Takayasu arteritis, independent of HLA-E genotype
Ruchika Goel et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2018)
Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study)
Yoshikazu Nakaoka et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Profiles of serum cytokine levels in Takayasu arteritis patients: Potential utility as biomarkers for monitoring disease activity
Natsuko Tamura et al.
JOURNAL OF CARDIOLOGY (2017)
What is new in management of Takayasu arteritis?
Gokhan Keser et al.
PRESSE MEDICALE (2017)
A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu Arteritis
Carol A. Langford et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Infliximab and etanercept have distinct actions but similar effects on cytokine profiles in rheumatoid arthritis
Masaru Takeshita et al.
CYTOKINE (2015)
Recent advances in the medical management of Takayasu arteritis: an update on use of biologic therapies
Alison Clifford et al.
CURRENT OPINION IN RHEUMATOLOGY (2014)
The diagnosis and classification of giant cell arteritis
Gideon Nesher
JOURNAL OF AUTOIMMUNITY (2014)
Effects of glucocorticoids and tumor necrosis factor-alpha inhibitors on both clinical and molecular parameters in patients with Takayasu arteritis
Raffaele Serra et al.
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS (2014)
Tumor necrosis factor alpha inhibitors in patients with Takayasu's arteritis refractory to standard immunosuppressive treatment: cases series and review of the literature
P. I. Novikov et al.
CLINICAL RHEUMATOLOGY (2013)
Rapid control of disease activity by tocilizumab in 10 'difficult-to-treat' cases of Takayasu arteritis
Ruchika Goel et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2013)
Outcomes of Patients with Takayasu Arteritis Treated with Infliximab
Fabio Bonilla-Abadia et al.
JOURNAL OF RHEUMATOLOGY (2013)
Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010)
Ramnath Misra et al.
RHEUMATOLOGY (2013)
TNF inhibitor therapy for rheumatoid arthritis (Review)
Xixi Ma et al.
BIOMEDICAL REPORTS (2013)
Efficacy and tolerance of infliximab in refractory Takayasu arteritis: French multicentre study
Arsene Mekinian et al.
RHEUMATOLOGY (2012)
Tumor necrosis factor inhibitors in patients with Takayasu arteritis: Experience from a referral center with long-term followup
Jean Schmidt et al.
ARTHRITIS CARE & RESEARCH (2012)
Role of FDG PET-CT in Takayasu Arteritis
Daisuke Tezuka et al.
JACC-CARDIOVASCULAR IMAGING (2012)
Pentraxin-3 as a Marker of Disease Activity in Takayasu Arteritis
Lorenzo Dagna et al.
ANNALS OF INTERNAL MEDICINE (2011)
Takayasu's arteritis progression on anti-TNF biologics: a case series
Mohammed Osman et al.
CLINICAL RHEUMATOLOGY (2011)
Sensitive Assessment of Activity of Takayasu's Arteritis by Pentraxin3, a New Biomarker
Takashi Ishihara et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
The American College of Rheumatology 1990 criteria for the classification of takayasu arteritis
William P. Arend et al.
ARTHRITIS AND RHEUMATISM (2010)
Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up
E. S. Molloy et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Infliximab in Takayasu arteritis: a safe alternative?
Zaharenia Th. Karageorgaki et al.
CLINICAL RHEUMATOLOGY (2007)
Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients
Kathleen Maksimowicz-McKinnon et al.
ARTHRITIS AND RHEUMATISM (2007)
High TNF-α and low IL-2 producing T cells characterize active disease in Takayasu's arteritis
NK Tripathy et al.
CLINICAL IMMUNOLOGY (2006)
Infliximab is effective for Takayasu arteritis refractory to glucocorticoid and methotrexate
Fumiko Tanaka et al.
INTERNAL MEDICINE (2006)
Tumor necrosis factor and granuloma biology: Explaining the differential infection risk of etanercept and infliximab
RS Wallis et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2005)
Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis
GS Hoffman et al.
ARTHRITIS AND RHEUMATISM (2004)
Production of the soluble pattern recognition receptor PTX3 by myeloid, but not plasmacytoid, dendritic cells
A Doni et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Mechanisms of disease: Medium- and large-vessel vasculitis
CM Weyand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
PTX3, a prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans
G Peri et al.
CIRCULATION (2000)
分享论文
